Skip to content

The clinical research on Li-ESW in the treatment of erectile dysfunction

The clinical research on Li-ESW in the treatment of erectile dysfunction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013804
Enrollment
Unknown
Registered
2017-12-10
Start date
2017-12-10
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male erectile dysfunction

Interventions

Group Li-ESWT:Li-ESWT treatment, once a week, every time 20min, for 24 weeks
Group PDE5i:Oral PDE5i daily 5mg, for 24 weeks
Group Li-ESWT+PDE5i:Li-ESWT treatment, once a week, every time 20min, for 24 weeks,Oral PDE5i daily 5mg, for 24 weeks

Sponsors

Renji Hospital, Shanghai Jiao Tong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 60 years old, ED history = 6 months; 2. IIEF-5 8 to 21; 3. PDE5 inhibitor treatment was poor or ineffective; 4. consider vascular ED patients.

Exclusion criteria

Exclusion criteria: 1. there is acute and chronic medical history, major trauma and surgical history; 2. have long-term medication history; 3. unstable myocardial infarction and history of cerebral infarction; Source shock, severe heart failure, severe ventricular arrhythmia and other medical history; 4. serious diseases such as malignant tumors, chronic liver and kidney disease.

Design outcomes

Primary

MeasureTime frame
IIEF-5;CDDU;NPT;

Secondary

MeasureTime frame
IMT;FMD;SI;BP;BMI;

Countries

China

Contacts

Public ContactMujun Lu

Renji Hospital, Shanghai Jiaotong University School of Medicine

lumujun@163.com+86 13020156427

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026